A Single and Multiple Ascending Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of KP-1199
Clinical trial NCT03880487 · TERMINATED
Trial details
- NCT number
- NCT03880487
- Sponsor
- Kalyra Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-12
- Primary completion
- 2020-04-21
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.